Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)

Also known as: Myelodysplastic Syndrome With Excess Blasts-2

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB06182	Talabostat	1	Recruiting	1
DB00928	Azacitidine	2	Completed	1
DB00242	Cladribine	2	Completed	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00091	Cyclosporine	2	Completed	1
DB00987	Cytarabine	2	Completed	1
DB00987	Cytarabine	2	Terminated	1
DB00694	Daunorubicin	2	Terminated	1
DB00099	Filgrastim	2	Completed	1
DB01073	Fludarabine	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Completed	2
DB00888	Mechlorethamine	2	Completed	1
DB01042	Melphalan	2	Completed	1
DB16620	Methopterin	2	Active Not Recruiting	1
DB16620	Methopterin	2	Completed	1
DB00563	Methotrexate	2	Active Not Recruiting	1
DB00563	Methotrexate	2	Completed	1
DB01204	Mitoxantrone	2	Completed	1
DB00688	Mycophenolate mofetil	2	Active Not Recruiting	1
DB00688	Mycophenolate mofetil	2	Completed	1
DB00877	Sirolimus	2	Completed	1
DB00864	Tacrolimus	2	Active Not Recruiting	1
DB00864	Tacrolimus	2	Completed	1
DB04572	Thiotepa	2	Active Not Recruiting	1
DB04572	Thiotepa	2	Completed	1
DB03754	Tromethamine	2	Active Not Recruiting	1
DB03754	Tromethamine	2	Completed	1
DB11999	Vosaroxin	2	Completed	1
DB13874	Enasidenib	3	Recruiting	1
DB12141	Gilteritinib	3	Active Not Recruiting	1
DB14568	Ivosidenib	3	Recruiting	1
DB06595	Midostaurin	3	Active Not Recruiting	1